Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
(Correcting forecasted trading profit margin for 2023)
Smith & Nephew PLC on Thursday said it appointed a successor to outgoing Chief Financial Officer Anne-Francoise Nesmes.
It also said revenue increased 8.8% in the third quarter, and proclaimed an optimistic outlook for the full year.
The London-based medical technology company, which previously announced in August that Nesmes was to leave, has now appointed John Rogers as her successor.
Smith & Nephew said Rogers will join as CFO-designate on December 1 and following a period of induction, will join the board as CFO in the first quarter of 2024.
Rogers was most recently CFO at WPP PLC, Smith & Nephew noted, where he ‘successfully led the implementation of their global transformation programme’. This was after serving as CFO at J Sainsbury PLC.
‘John is a highly regarded chief financial officer with a proven track record operating around the world and across a number of industry sectors. His extensive experience in transformation and capital markets is especially important given Smith & Nephew’s focus on driving greater shareholder value,’ said Chair Rupert Soames.
Smith & Nephew also updated on its third quarter performance. It said revenue rose 8.8% to $1.36 billion from $1.25 billion a year earlier, representing underlying revenue growth of 7.7% and reported growth of 8.5% including an 80 basis point foreign exchange tailwind.
Orthopaedics revenue was up 8.3%, which it said was partly due to product launches and strategy improvements driving higher growth from Trauma & Extremities. Sports Medicine & ENT revenue was up 11%, with Smith & Nephew noting continued growth across most markets offsetting weakness in China.
Meanwhile, Advanced Wound Management revenue was up 3.6%, with double-digit growth from Smith & Nephew’s negative pressure portfolio but a slower quarter from Advanced Wound Bioactives.
Looking ahead, it expects full-year 2023 underlying revenue growth to be towards the higher end of the guidance range of 6.0% to 7.0%. Its trading profit margin is now expected to be around 17.5%, reflecting headwinds from China.
Shares in Smith & Nephew were up 4.5% to 964.80 pence each in London on Thursday afternoon.
Copyright 2023 Alliance News Ltd. All Rights Reserved.